Heraeus highlights increasing platinum demand from the pharmaceutical sector
Global technology group Heraeus says in its ‘Precious Appraisal’ report that pharmaceutical platinum demand is expected to rise steadily moving forward. It explains that, with the World Health Organisation estimating that new cancer cases could rise by 50% by 2040, platinum-based drugs will be pivotal to efficient and effective treatments, propping up this rising pharmaceutical platinum demand.
Global technology group Heraeus says in its ‘Precious Appraisal’ report that pharmaceutical platinum demand is expected to rise steadily moving forward. It explains that, with the World Health Organisation estimating that new cancer cases could rise by 50% by 2040, platinum-based drugs will be pivotal to efficient and effective treatments, propping up this rising pharmaceutical platinum demand.
